Oximeter for reliable clinical determination of blood oxygen saturation in a fetus

• US 5,494,032 A
• Filed: 05/23/1994
• Issued: 02/27/1996
• Est. Priority Date: 07/12/1991
• Status: Expired due to Term

• Current Assignee: Sandia Corporation (Martin Marietta Corporation)
• Original Assignee: Sandia Corporation (Martin Marietta Corporation)
• Inventors: Ward, Kenneth J., Haaland, David M., Robinson, Mark R.
• Primary Examiner(s): Sykes, Angela D.
• Assistant Examiner(s): NASSER, ROBERT L
• Application Number:
  US08/247,297
• Time in Patent Office: 645 Days
• Field of Search: 128/633-634, 128/664-666, 356/41
• US Class Current: 600/323
• CPC Class Codes: A61B 5/14542 for measuring blood gases A61B5/14551 takes precedence
• CPC Class Codes: A61B 5/1464 specially adapted for foetal tissue
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: G01N 21/31 Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry G01N21/72 takes precedence
• CPC Class Codes: G01N 2201/129 Using chemometrical methods

Abstract

With the crude instrumentation now in use to continuously monitor the status of the fetus at delivery, the obstetrician and labor room staff not only over-recognize the possibility of fetal distress with the resultant rise in operative deliveries, but at times do not identify fetal distress which may result in preventable fetal neurological harm. The invention, which addresses these two basic problems, comprises a method and apparatus for non-invasive determination of blood oxygen saturation in the fetus. The apparatus includes a multiple frequency light source which is coupled to an optical fiber. The output of the fiber is used to illuminate blood containing tissue of the fetus. In the preferred embodiment, the reflected light is transmitted back to the apparatus where the light intensities are simultaneously detected at multiple frequencies. The resulting spectrum is then analyzed for determination of oxygen saturation. The analysis method uses multivariate calibration techniques that compensate for nonlinear spectral response, model interfering spectral responses and detect outlier data with high sensitivity.

Claims

1. A quantitative analysis instrument for noninvasive measurement of blood oxygen saturation in a fetus, said instrument comprising:

a. a source of at least four different wavelengths of light, at least some of said wavelengths being in the range from 500 to 1000 nm;

b. optical means for introducing said wavelengths into said fetus and for collecting at least a portion of said wavelengths that are reflected back from said fetus;

c. a device for positioning said optical means relative to said fetus, whereby at least a portion of said wavelengths are introduced into said fetus and said portion of said reflected wavelengths are collected;

d. at least one detector positioned relative to said optical means for measuring the spectral intensities of said reflected wavelengths during the diastolic portion of the cardiac cycle of said fetus, to obtain a diastolic set of spectral intensities v. wavelengths, and for measuring the spectral intensities of said reflected wavelengths during the systolic portion of said cardiac cycle, to obtain a systolic set of spectral intensities v. wavelengths;

e. electronics including a microprocessor and memory means for, (i) storing said diastolic set of spectral intensifies v. wavelengths and said systolic set of spectral intensities v. wavelengths;

(ii) processing said diastolic and systolic sets of spectral intensities to determine a measure of change between said diastolic and systolic sets to obtain a third set of spectral intensifies v. wavelengths, and (iii) processing said third set of spectral intensifies v. wavelengths to determine a measure of oxygen saturation, said memory means including a multivariate algorithm and a multivariate calibration model, said algorithm using at least three variables; and

f. means, for indicating said determined measure of oxygen saturation.

2. The analysis instrument of claim 1, wherein said algorithm is selected from the group including PLS, PCR, CLS, Q-matrix, cross-correlation, Kalman filtering and MLR.

3. The analysis instrument of claim 2, wherein said algorithm is an algorithm capable of utilizing more discrete spectral intensities per sample than the number of calibration samples used to generate said model.

4. The analysis instrument of claim 1, wherein said electronics also includes an electrode for measuring the electrical activity of the heart of said fetus, to facilitate the determination of said systolic portion and said diastolic portion of said cardiac cycle.

5. The analysis instrument of claim 1, wherein said electronics further includes means for detecting outliers.

6. A method for noninvasive measurement of blood oxygen saturation in a fetus, said method comprising the steps of:

a. generating at least four different wavelengths of light, some of said wavelengths being in the range from 500 to 1000 nm;

b. irradiating said fetus with said wavelengths and collecting a portion of said wavelengths that are reflected back from said fetus;

c. measuring the spectral intensities of said reflected wavelengths during the diastolic portion of the cardiac cycle of said fetus, to obtain a diastolic set of spectral intensities v. wavelengths, and measuring the spectral intensities of said reflected wavelengths during the systolic portion of said cardiac cycle, to obtain a systolic set of spectral intensities v. wavelengths; and

d. determining a third set of spectral intensities v. wavelengths from said diastolic and systolic sets of spectral intensities, and determining a measure of oxygen saturation from said third set of spectral intensities v. wavelengths utilizing a multivariate algorithm and a multivariate calibration model, said algorithm using at least three variables.

7. The method as set forth in claim 6, wherein said step of determining oxygen saturation includes utilizing an algorithm selected from the group including PLS, PCR, CLS, Q-matrix, cross-correlation, Kalman filtering and MLR.

8. The method as set forth in claim 7, wherein said algorithm is capable of utilizing more discrete spectral intensities per sample than the number of calibration samples used to generate said model.

9. The method as set forth in claim 6, further including the step of determining whether said third set of spectral intensities v. wavelengths from said fetus is an outlier by comparing said third set of spectral intensities v. wavelengths from said fetus with a set of spectral intensities v. wavelengths obtained from irradiating calibration samples.

10. The method as set forth in claim 9, wherein said determination of whether said third set of spectral intensities v. wavelengths from said fetus represents an outlier includes the step of comparing said third set of spectral intensities v. wavelengths from said fetus to said set of spectral intensities v. wavelengths from said calibration samples, to determine a measure of the magnitude of the difference between said third set of spectral intensities v. wavelengths from said fetus and said set of spectral intensities v. wavelengths from said calibration samples.

11. The method as set forth in claim 10, further including using a statistical test to indicate the probability of said magnitude being caused by random chance, and further including the step of classifying said third set of spectral intensities v. wavelengths from said fetus as representing an outlier when said probability is determined to be too low.

12. The method as set forth in claim 6, further including the step of pretreating of said sets of spectral intensities v. wavelengths from said fetus.

13. The method as set forth in claim 12, wherein said pretreating includes the steps of centering, scaling, normalizing, taking first or higher order derivatives, smoothing, fourier transforming or linearization.

14. The method as set forth in claim 6, including accomplishing said determination of said diastolic portion and said systolic portion of said cardiac cycle by concurrently measuring the electrical activity of the heart of said fetus.